Cargando…
Association of Metformin Treatment with Risk for Death in Diabetic Patients with Concomitant Gastric Cancer
SIMPLE SUMMARY: During the 5-year follow-up within the study period, the cumulative incidence of all-cause death was notably lower in the metformin treatment group compared to the non-treatment group (27.5% vs. 32.8%). The analysis further revealed a significantly reduced hazard ratio (HR) for all-c...
Autores principales: | Joo, Jae-Hong, Zhang, Hyun-Soo, Chun, Jiyeon, Park, Eun-Cheol, Park, Sohee |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10452498/ https://www.ncbi.nlm.nih.gov/pubmed/37627162 http://dx.doi.org/10.3390/cancers15164134 |
Ejemplares similares
-
Anti-platelet effects of epigallocatechin-3-gallate in addition to the concomitant aspirin, clopidogrel or ticagrelor treatment
por: Joo, Hyung Joon, et al.
Publicado: (2018) -
Effect of metformin monotherapy and dual or triple concomitant therapy with metformin on glycemic control and lipid profile management of patients with type 2 diabetes mellitus
por: Lin, Yan-Yu, et al.
Publicado: (2022) -
Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2008
por: Jung, Kyu-Won, et al.
Publicado: (2011) -
Prediction of Cancer Incidence and Mortality in Korea, 2011
por: Jung, Kyu-Won, et al.
Publicado: (2011) -
Spontaneous Remission and Concomitant Progression in a Patient with DLBCL
por: Han, Eun Ji, et al.
Publicado: (2020)